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Abstract
Background: The chicken genome contains a BBP-A gene showing similar characteristics to avidin
family genes. In a previous study we reported that the BBP-A gene may encode a biotin-binding
protein due to the high sequence similarity with chicken avidin, especially at regions encoding
residues known to be located at the ligand-binding site of avidin.
Results: Here, we expand the repertoire of known macromolecular biotin binders by reporting a
novel biotin-binding protein A (BBP-A) from chicken. The BBP-A recombinant protein was
expressed using two different expression systems and purified with affinity chromatography,
biochemically characterized and two X-ray structures were solved – in complex with D-biotin
(BTN) and in complex with D-biotin D-sulfoxide (BSO). The BBP-A protein binds free biotin with
high, "streptavidin-like" affinity (Kd ~ 10-13 M), which is about 50 times lower than that of chicken
avidin. Surprisingly, the affinity of BBP-A for BSO is even higher than the affinity for BTN.
Furthermore, the solved structures of the BBP-A – BTN and BBP-A – BSO complexes, which share
the fold with the members of the avidin and lipocalin protein families, are extremely similar to each
other.
Conclusion: BBP-A is an avidin-like protein having a β-barrel fold and high affinity towards BTN.
However, BBP-A differs from the other known members of the avidin protein family in thermal
stability and immunological properties. BBP-A also has a unique ligand-binding property, the ability
to bind BTN and BSO at comparable affinities. BBP-A may have use as a novel material in, e.g.
modern bio(nano)technological applications.
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Several biotin-binding proteins have been characterized
from egg-laying vertebrates. The best known of these pro-
teins is chicken avidin (AVD) [1-4]. This tetrameric ~60
kDa egg-white protein, together with its bacterial
homologs streptavidin and bradavidin [5-7], has a fasci-
nating feature, the ability to bind a small water soluble
vitamin, D-biotin (BTN), with tremendous affinity (Kd ≈
10-15 M for AVD) [5]. The formation of the extraordinary
strong protein-ligand complex is a result of "perfect"
structural complementarity between the (strept)avidin
ligand-binding site and BTN [8,9], and optimized "pack-
ing" of the overall tertiary and quaternary structure, too
[5,10]. Although BTN is thought to be the natural ligand
of (strept)avidin, these proteins are known to bind natu-
rally-occurring as well as synthetic BTN analogous and
their derivatives, which include the biotechnologically
valuable 2-iminobiotin, 4'-hydroxyazobenzene-2-carbox-
ylic acid (HABA) and desthiobiotin (for a review, see
[1,5]). However, (strept)avidin has clearly weaker affinity
for ligands other than BTN. The biological role of AVD is
still partially unclear, but it has been postulated to func-
tion as an antimicrobial defence protein in chicken by
ensuring that no free biotin is present in egg white; a vita-
min required for the growth of bacteria [1]. Nevertheless,
it is the numerous bio(nano)technological applications,
where AVD's unique biotin-binding property has been
utilized, which have made AVD one of the most well-
known proteins.
In addition to AVD of chicken egg-white, other proteins
capable of binding BTN tightly, biotin-binding protein I
(BBP-I) [11-13] and II (BBP-II) [14,15] of chicken egg-
yolk, have been reported. Nothing is known about the
affinity of BBP-I/II for ligands other than BTN. Although
immunologically similar and having comparable N-ter-
minal sequences [15,16], BBP-I and BBP-II differ in their
thermal stability, BBP-I being more stable than BBP-II
[14]. The biological functions of the two BBP forms are
only partly resolved, but they are known to be synthesized
in the liver and believed to transport BTN via plasma to
the egg-yolk [14,16,17]. More specifically, it is believed
that BBP-I has a general role as a transport protein in hen
plasma, whereas BBP-II may be needed for the efficient
deposition of BTN into the yolk of maturating oocytes
[14].
There is a substantial evidence that the quaternary struc-
ture of BBP-I/II is tetrameric, but it is not clear whether the
tetramers are formed as a result of assembling four mon-
omers or if the tetramers result from limited proteolysis of
a single polypeptide containing all the binding sites
[13,16]. Evidence for the former hypothesis became avail-
able when the putative genes and cDNAs encoding the
BBP-I/II proteins were reported in 2005 by Niskanen and
co-workers [18]: the exon-intron structures of the BBP
genes [18], named as BBP-A and BBP-B, mimic those of
AVD and avidin-related genes (AVRs) [19-21] and they
encode proteins with a single ligand binding site per
polypeptide chain. It is worth mentioning that it is not yet
completely clear whether the BBP-A and BBP-B genes
really encode for either of the earlier characterized BBP-I
and BBP-II proteins; BBP-A in particular seems to encode
a novel protein, BBP-A, not characterized before [18].
In the present study, we show that the chicken BBP-A gene
encodes a functional homotetrameric protein. We report
two different X-ray structures of BBP-A, one in complex
with BTN and an other one in complex with D-biotin D-
sulfoxide (BSO), at 2.1 Å and 1.75 Å resolution, respec-
tively. To our knowledge, no other structures of any pro-
teins in complex with BSO have been reported before.
Using several biochemical methods, we show that BBP-A
binds BSO even tighter than BTN. A comparative study of
the ligand-binding and physicochemical properties of
BBP-A and AVD are presented together with data from
site-directed mutagenesis.
Results
Biochemical characterization of BBP-A
BBP-A, expressed both in E. coli (bBBP-A) and in insect
cells (iBBP-A), was isolated and purified using 2-iminobi-
otin affinity chromatography. A typical yield was 5 mg of
pure protein per one litre of culture medium for both
expression systems. The mutations A74S and T118F,
which were made in order to study the differences in the
molecular origin of the biotin-binding affinity and the
thermal stability of BBP-A as compared to chicken AVD,
had no significant effect on the protein yields. The iso-
lated proteins were shown to be over 95% pure using SDS-
PAGE analysis (data not shown). A molecular weight of
13999.0 Da was determined for the expressed bBBP-A
using mass spectrometry, and it matched the molecular
weight calculated from the expression construct.
The oligomeric state of bBBP-A, bBBP-A(A74S), bBBP-
A(T118F), iBBP-A, bAVD and wtAVD in solution was ana-
lysed using gel filtration chromatography. All of the pro-
teins eluted as single peaks in this analysis, demonstrating
the homogeneity of the samples. The apparent molecular
weights of iBBP-A (60.8 kDa) and wtAVD (62.5 kDa),
based on gel filtration analysis, corresponded well with
the theoretical molecular weights for their respective
tetramers. As expected, the proteins produced in bacterial
cells showed apparent molecular weights lower than the
corresponding proteins expressed in insect cells, at least
partially due to the absence of glycosylation (bBBP-A,
42.7 kDa and bAVD, 55.3 kDa). The mutations A74S and
T118F had no effect on the appearance of BBP-A in the gel
filtration analysis. Nor did the addition of BTN to thePage 2 of 20
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of the analysed proteins. This, together with the results
showing that BTN significantly stabilizes tetramers of
bBBP-A (see below; Table 1 and Figure 1), supports the
idea that the quaternary structure of bBBP-A is tetrameric,
an idea that is also supported by the crystal structures of
bBBP-A – BSO and bBBP-A – BTN (see below).
The amino acid sequence of BBP-A contains one putative
N-glycosylation site (Figure 2), which corresponds to an
N-glycosylation site known to be present and glycosylated
in AVD [1]. To see whether iBBP-A was also glycosylated,
the protein was treated with Endoglycosidase H and ana-
lysed on SDS-PAGE (Figure 3). After the deglycosylation
treatment, the iBBP-A protein had a molecular weight
comparable to that of bBBP-A, a molecular weight clearly
lower than the molecular weight of the untreated iBBP-A
sample. This result, together with the control data
(wtAVD), indicates that the N-glycosylation site of BBP-A
was indeed glycosylated in insect cells and the size of the
attached carbohydrate is comparable to that present on
wtAVD.
The immunological cross-reactivity of BBP-A and wtAVD
was studied with two polyclonal antibodies made against
chicken AVD (Figure 4). Neither of the antibodies did
cross-react with BBP-A in a Western blotting analysis. The
reactivity of both antibodies was significantly weaker with
iBBP-A (10 μg) than in the case of a 100-fold dilution of
wtAVD (0.1 μg). In dot-blot analysis, only one antibody,
the TdaVIII antibody, was used to test whether it detects
iBBP-A and bBBP-A. In agreement with the immunoblot
analysis, no or only negligible cross-reactivity was
observed.
Stability of the tetrameric assembly of BBP-A
The thermal stability of the tetrameric form of BBP-A was
analysed in the presence of 2-mercaptoethanol using an
SDS-PAGE-based method described in [22]. Both bBBP-A
and iBBP-A appeared mainly in monomeric forms on
SDS-PAGE gels already at room temperature in the
absence of BTN, whereas addition of BTN stabilised the
tetrameric form, which was stable until the temperature
was raised to 70°C (Table 1 and Figure 1). In the presence
of BTN, glycosylated iBBP-A had slightly better thermal
stability (Tr = 75°C) compared to bBBP-A (Tr = 70°C).
Both bBBP-A and iBBP-A were clearly more thermally
labile than wtAVD. The mutations A74S and T118F had
no significant effect on the stability of the tetrameric
forms of bBBP-A (Table 1, Figure 1).
Differential scanning calorimetry (DSC) was not applica-
ble to the bBBP-A forms in the absence of ligands, since a
clear, single denaturation temperature could not be meas-
ured for these proteins. For bBBP-A, two peaks at around
51°C and 68°C were obtained. In the presence of BTN,
however, the value of Tm was around 100°C for all bBBP-
A forms. These values are significantly lower in compari-
son to those measured for wtAVD (Table 1). Furthermore,
the thermal stability of bBBP-A and AVD was analysed in
the presence of BSO and D-biotin sulfone (Table 2). Only
negligible differences were, however, found between the
effects of these two ligands and BTN on the thermal stabil-
ities of bBBP-A and AVD.
The overall X-ray structures of BBP-A
The crystal structures of bBBP-A in complex with BTN and
BSO were solved at 2.1 Å and 1.75 Å resolution, respec-
tively. The statistics for the structure determinations are
summarized in Table 3. The overall BBP-A – BTN and
Table 1: Biochemical properties of different BBP-A forms.
Gel filtration SDS-PAGE-based 
thermostability assay
Dissociation of 
fluorescent BTN 
(25°C)
DSC
Elution time (min) Molecular mass (kDa)a Tr (°C) kdiss 
(10-5 s-1)
Release 
1 h (%)
Tm (°C)
-BTN +BTN -BTN +BTN -BTN +BTN -BTN +BTN
bBBP-A 29.9 30.1 42.7 40.9 N. D. 70 54.8 86 N. A. 103.4
bBBP-A 
(A74S)
30.0 30.1 41.9 40.8 N. D. 75 47.1 83 N. A. 103.2
bBBP-A 
(T118F)
30.1 29.9 41.3 42.7 N. D. 70 69.1 94 N. A. 102.3
iBBP-A 28.4 28.4 60.8 59.7 N. D. 75 20.4 53 N. M. N. M.
AVD 28.2 28.2 62.5 63.6 60b 90b 2.0 10 83.5c 117.0
bAVD 28.8 28.8 55.3 55.1 60b 90b 1.1 5 N. M. N. M.
N. D. Protein appeared mainly in monomeric form already at room temperature; N. A. Not applicable; N. M. Not measured.
aMolecular mass calculated from the measured elution times of thyroglobulin (670 kDa), gamma-globulin (158 kDa), BSA (67 kDa), ovalbumin (44 
kDa) and myoglobin (17 kDa).
bResults from ref. [30].
cResults from ref. [33].Page 3 of 20
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SDS-PAGE based analysis of the thermal stability of the tetramers of BBP-AFigure 1
SDS-PAGE based analysis of the thermal stability of the tetramers of BBP-A. Samples saturated with BTN (+Biotin) 
prior to analysis as well as samples without added BTN (-Biotin) are shown. (a) bBBP-A, (b) bBBP-A in the presence of BTN 
and (c) bBBP-A(A74S) in the absence and presence of BTN. After acetylation in vitro, the samples were subjected to thermal 
treatment in SDS-PAGE sample buffer containing 2-mercaptoethanol and SDS. The different temperatures used in the analysis 
are indicated in the upper part of the figure (°C). The molecular weights of the standard proteins (Bio-Rad) are shown on the 
left.
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other; the Cα atoms of these structures superimpose with
an rmsd of < 0.2 Å. The BBP-A structures consist of four
identical subunits, each subunit adopting a β-barrel fold
of eight anti-parallel β-strands with an α-helix positioned
between the β7- and β8-strands (Figure 5a,b). The BTN/
BSO-binding site is located at the open end of each β-bar-
rel. The overall fold of BBP-A is similar to that seen for the
known structures of the AVD family complexes, i.e.
streptavidin-BTN [8], AVD-BTN [9,23], AVR2-BTN [24]
and AVR4-BTN [25] complexes. The solvent accessible
surface area is, however, over 10% larger in the BBP-A
structures (> 21000 Å2) compared to the AVD-BTN struc-
tures (< 19000 Å2 [PDB: 1AVD and 2AVI]). The electro-
static surface properties of BBP-A and AVD differ, too,
BBP-A having a seemingly more positively charged surface
than AVD (Figure 5c–f).
Mode of BTN and BSO binding
The biotin-binding site of the BBP-A – BTN structure
mimics the biotin-binding site of AVD [9,23]. The amino
acid residues within 4 Å of BTN in the complex with BBP-
A (Asn12, Leu14, Ser16, Tyr33, Thr35, Val37, Thr38,
Ala39, Thr40, Trp71, Phe73, Ala74, Ser76, Thr78, Phe80,
Trp98, Leu100, Glu102, Asn119 and Trp111) are not only
highly conserved but also have conformations similar to
those seen in AVD (Figure 6a). Actually, only one polar
(Glu102) and one hydrophobic residue (Ala74) within 4
Å of BTN are not conserved between the BBP-A – BTN and
AVD-BTN complex [PDB: 2AVI] structures. The side-chain
oxygen of Glu102 of BBP-A is hydrogen bonded to one of
the valeric oxygen atoms of BTN, whereas in AVD the
equivalent residue, Ser101, can not form a hydrogen bond
to the valeric oxygen because the distance between the two
atoms is too long (5.8 Å). The methyl carbon of Ala74 of
BBP-A, on the other hand, is positioned only 3.7 Å away
from the valeric O10B atom of BTN (numbering accord-
ing to [26]), but is not likely to be hydrogen bonded with
BTN unlike the side-chain oxygen atom of the corre-
sponding Ser73 in AVD, which is hydrogen bonded to
BTN.
In addition to the BBP-A – BTN complex structure, we
solved the X-ray structure of BBP-A – BSO, too. To our
knowledge, BSO is not found in any other protein struc-
ture presently within the Protein Data Bank (PDB) [27].
Electron density for the BSO ligand was clearly seen in the
difference map of the BBP-A – BSO structure (Figure 7).
The binding mode of BSO to BBP-A is surprisingly similar
to that of BTN (Figure 6b) despite the additional oxygen
atom that is covalently linked to the sulphur atom of the
bicyclic ring system of BSO but is missing from BTN. The
distance between the sulfur atom of BTN and the OG1
atom of Thr78 (3.4 Å), for example, is very close to the
BSO – Thr78 distance (3.6 Å). In the known AVD-BTN
Deglycosylation analysis of BBP-AFigure 3
Deglycosylation analysis of BBP-A. The BBP-A pro-
duced in insect cells was treated with Endo Hf glycosidase 
(Bi+) and analysed with SDS-PAGE. Untreated control sam-
ple (Bi) and BBP-A produced in bacteria (Bb) were also ana-
lysed. For comparison, the same analysis was performed for 
AVD isolated from chicken (Ac+). Chicken AVD control 
sample (Ac) as well as AVD produced in bacteria (Ab) [30] 
are also shown. The molecular weight markers are shown on 
both sides of the gel (14.4 and 21.5 kDa).
Sequence alignment of BBP-A and AVDFig re 2
Sequence alignment of BBP-A and AVD. Identical residues are shown in gray shading. The signal peptides are omitted 
from the alignment. Secondary structure elements are indicated according to the BBP-A – BSO structure (chain A). The amino 
acids within 4 Å of BSO in the BBP-A – BSO structure (and the equivalent residues in AVD) are boxed. The residues mutated 
in this study are indicated by an asterisk. The glycosylation site of BBP-A is indicated by an arrow.Page 5 of 20
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sponding distances are 3.2 Å and 3.8 Å. The only noticea-
ble difference around the ligands in the two BBP-A
structures was found at Glu102, which in the BBP-A – BTN
structure is hydrogen bonded to the valeric O10A atom of
BTN but in the BBP-A – BSO structure was observed either
to form a salt bridge with Arg115 (chains B and D) or to
hydrogen bond to a structural water molecule (chains A
and C). The difference in the conformation of Glu102 is
not likely to result from the varying crystal contacts of the
two BBP-A structures that crystallized as different space
groups (data not shown). Moreover, the overall confor-
mations of the BTN and BSO ligands bound to BBP-A
were very similar, too.
Subunit interfaces of BBP-A
Comparing BBP-A with AVD, we saw differences at subu-
nit interfaces 1–3 and 1–4, whereas the amino acid resi-
dues found at the 1–2 interface were conserved and had
similar conformations (numbering of subunit interfaces
according to [9]).
Of the three residues (Val116, Gly117 and Thr118) within
5 Å from each other at the 1–3 subunit interface of the
BBP-A – BSO structure (Figure 8a), valine and glycine are
conserved between BBP-A and AVD, while Thr118 is
replaced by Ile117 in the AVD structure. In BBP-A there is
no interaction equivalent to the hydrophobic or van der
Waals interactions introduced by the two Met96 residues
of AVD at the 1–3 subunit interface: in BBP-A, Met96 is
replaced by Ala97 and the distance between Ala97 in the
two subunits is about 11 Å. Generally, the 1–3 subunit
interface seems to be more loosely packed in BBP-A com-
pared to AVD, AVR4 [25] and even AVR2 [24] (data not
shown).
The total contact surface area of the 1–4 interface of BBP-
A – BSO is 2428 Å2, whereas the corresponding contact
surface area in AVD is 2319 Å2. Twenty-six of the 49
amino acid residues found at the 1–4 interface within a
contact radius of 4 Å are different between the BBP-A –
BSO and AVD-BTN [PDB: 2AVI] structures. Hydrophobic
residues located at the core of the 1–4 subunit interfaces
are well conserved in BBP-A and AVD, whereas several dif-
ferences among the polar residues were observed, espe-
cially at the interacting loop regions (Figure 8b,c). The
hydrogen bond found in AVD between the OE2 atom of
Glu28 of the β3 sheet and the NE2 nitrogen of His50 of
the β4 sheet, for example, is not seen in BBP-A where
Glu28 and His50 are respectively replaced by Thr28 and
Lys50. The hydrogen bond formed between the side-chain
atoms of Gln61 (L4,5 loop) and Glu103 (L7,8 loop) in
BBP-A is, in turn, missing from AVD, where the residues
are replaced by Thr60 and Ser102. Yet another example of
the differences at the 1–4 subunit region between BBP-A
and AVD was seen for the only α-helix and the β7-strand
Table 2: Dissociation of BTN and its oxidized forms from BBP-A and AVD. Fluorescence spectroscopy and radiobiotin dissociation 
analysis data at 40°C are shown. Binding enthalpies were measured by ITC at 25°C. bBBP-A and commercial chicken AVD was used in 
the analyses.
Ligand kdiss × 10-4 s-1 Enthalpy (kcal/mol) (ITC) Tm (°C) (DSC)
BBP-A AVD BBP-A AVD BBP-A
BSO 1.3a -29.3 ± 0.1 -25.9 ± 0.1 116.9 ± 0.2 100.4 ± 0.2
D-biotin sulfone 3.3a -25.1 ± 0.1 -21.4 ± 0.1 117.0 ± 0.0 101.4 ± 0.2
BTN 5.4b (4.4c) -22.6 ± 0.1 -20.5 ± 0.1 117.0 ± 0.7 103.4 ± 0.1
aFrom fluorescence spectroscopic analysis, excess of BTN was used as a competitive ligand.
bFrom fluorescence spectroscopic analysis, excess of BSO was used as a competitive ligand.
cValue obtained from [3H]-biotin dissociation analysis, excess of BTN was used as a competitive ligand.
Immunological cross-reactivity of chicken BBP-A and AVDFigure 4
Immunological cross-reactivity of chicken BBP-A and 
AVD. (a) Western blot analysis of 1/100, 1/10 and 1/1 
diluted samples of chicken AVD (10 μg) and undiluted bBBP-
A protein (10 μg). The polyclonal antibody TdaVII against 
AVD [51] was used as the primary antibody. (b) The same 
analysis as in A using another polyclonal antibody (University 
of Oulu, Finland). (c) Dot-blot analysis of BBP-A (10 μg) pro-
duced in bacteria 'b' and in insect cells 'i'. The polyclonal anti-
body TdaVII against AVD was used as the primary antibody. 
Serial dilutions of AVD (10 μg) were used as controls (the 
dilution factors are indicated in the figure).Page 6 of 20
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of Glu95 can form hydrogen bonds with the NE and NH2
atoms of the side chain of Arg107, whereas the atoms of
the respective residues, Lys94 and Ile106, of AVD may
introduce only van der Waals contacts. These and other
differences (Figure 8b,c) reflect the varying architecture of
the 1–4 interfaces in BBP-A and AVD.
Ligand-binding analyses
The dissociation rate of [3H]biotin from BBP-A was meas-
ured using a competitive dissociation assay (Figure 9;
Table 2). The analysis showed that bBBP-A has a dissocia-
tion rate about 100-fold higher than that of AVD [28],
indicating that the affinity for BTN is lower in bBBP-A
compared to AVD, but similar to that of streptavidin [29].
The dissociation rate of the fluorescent BTN conjugate
ArcDia™ BF560-biotin was, in turn, about 30-fold higher
for bBBP-A compared to wtAVD (Table 1). Interestingly,
iBBP-A had an almost three-fold slower dissociation rate
compared to bBBP-A. WtAVD showed a higher dissocia-
tion rate compared to the bAVD form produced in E. coli,
which is in line with previously reported observations
[30]. The A74S and T118F mutations of BBP-A did not sig-
nificantly affect the biotin-binding properties of BBP-A
(Table 1, Figure 9).
The biotin-binding characteristics of bBBP-A and wtAVD
studied by ITC analysis were similar for both proteins.
Because the binding of BTN was tight (Kd < 10-9 M) in both
cases, the binding constants could not be determined
directly from the ITC data (Figure 10). The binding
enthalpy could, however, be accurately determined, and
the obtained values are listed in Table 2. In addition to
BTN, the binding of BSO and D-biotin sulfone to wtAVD
and bBBP-A were analysed using ITC (Table 2). The oxi-
dised BTN forms exhibited a slightly higher binding
enthalpy compared to BTN for both proteins studied.
Overall, ligand binding to AVD released more heat, but a
rather similar variation in the binding enthalpies of the
studied ligands was observed in BBP-A and AVD. There-
fore, the ITC analysis of the enthalpy of binding does not
suggest different ligand preferences for BBP-A and AVD.
Table 3: Data collection and structure determination statistics for BBP-A
Data collectiona BBP-A – BTN BBP-A – BSO
Wavelength (Å) 1.063 1.063
Beamline I711 (MAX-lab) I711 (MAX-lab)
Detector MarCCD 165 MarCCD 165
Resolution (Å) 25-2.1 (2.2-2.1) 25-1.75 (1.85-1.75)
Unique observations 10571 (1351) 26447 (3993)
I/sigma 14.06 (4.31) 12.78 (3.24)
Rfactor (%)b 10.5 (48.6) 7.7 (48.2)
Completeness 99.9 (100) 99.9 (100)
Redundancy 8.6 (8.7) 4.8 (4.8)
Refinement
Space group I4122 P21212
Unit cell:
a, b, c (Å) 61.7, 61,7, 179.7 79.7, 56.0, 57.1
α, β, γ (°) 90, 90, 90 90, 90, 90
Monomers (asymmetric unit) 1 2
Resolution (Å) 25-2.1 25-1.75
Rwork (%) 19.5 19.3
Rfree (%) 22.0 23.3
Protein atoms 969 1965
Heterogen atoms 22 34
Solvent atoms 61 212
R.m.s.d:
Bond lengths (Å) 0.014 0.014
Bond angles (°) 1.6 1.6
Ramachandran plot:
Residues in most favored regions 93.3 93.3
Residues in additional allowed regions 6.7 6.7
Residues in generously allowed regions 0 0
Residues in disallowed regions 0 0
aThe numbers in parenthesis refer to the highest resolution bin.
bObserved R-factor from XDS [53].Page 7 of 20
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The overall X-ray structure of chicken BBP-AFigure 5
The overall X-ray structure of chicken BBP-A. (a, b) A tetrameric ribbon model of the BBP-A – BSO structure. (c, d) 
Electrostatic potentials mapped onto the molecular surface of the BBP-A – BSO structure. (e, f) Electrostatic potentials 
mapped onto the molecular surface of the AVD [PDB: 2AVI] [23] structure after superimposition on the BBP-A structure. The 
views shown in (a), (c) and (e) are rotated 45° around the X-axis in (b), (d) and (f). The BSO and BTN ligands of the BBP-A – 
BSO and AVD structures, respectively, are shown as spheres. The yellow arrows pinpoint visible parts of the valeric acid tails 
of BSO and BTN seen in (d), (e) and (f).
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The binding mode of BTN and BSOFigure 6
The binding mode of BTN and BSO. (a) BTN (thick sticks) and the amino acids within 4 Å of BTN in the BBP-A – BTN 
and AVD [PDB: 2AVI] structures are shown. The carbon atoms of residues from subunit 1 of the BBP-A and AVD structures 
are coloured light grey and blue, respectively. The carbon atoms of Trp111 (Trp110) from subunit 2 of BBP-A (AVD) are col-
oured green (cyan). The amino acids of BBP-A (AVD) are numbered. The labels of the non-conserved residues are indicated 
with a yellow background. (b) BTN and BSO (thick sticks), and the amino acids within 4 Å of the ligands in the BBP-A – BTN 
and BBP-A – BSO structures are shown. The carbon atoms of residues from subunits 1 of the BBP-A – BTN and BBP-A – BSO 
structures are coloured light grey and light red, respectively. The carbon atoms of Trp111 from subunit 2 of the BBP-A – BTN 
and BBP-A – BSO structure are coloured green and dark red, respectively. The amino acids are numbered. Glu102, whose side 
chain has a different conformation in the BBP-A – BTN and BBP-A – BSO structures, is labelled with a yellow background.
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bBBP-A and wtAVD were studied, too (Figure 11). All
biotin forms, BTN, BSO and D-biotin sulfone, enhanced
the emission intensity of BBP-A. In contrast, only D-biotin
sulfone increased the emission intensity of AVD, whereas
BSO and especially BTN decreased the emission intensity
of AVD. Compared to the ligand-free proteins, for each of
the ligand-protein combinations the maximum in the
emission spectra moved towards the shorter blue wave-
lengths. Altogether, these results indicate differences in
the ligand-protein interactions between BBP-A and AVD,
particularly reflecting variation in the local environment
of tryptophan residues [31].
EST database search
Chicken EST databases were searched using NCBI blastn
[32] and the BBP-A and AVD cDNAs as query sequences.
The search resulted in 9 significant (E-value < 1 × 10-100
and score > 400) hits in the case of BBP-A, whereas the
cDNA of AVD yielded 94 hits. Further analysis of the BBP-
A hits showed that they correspond to mRNAs isolated
from kidney and the adrenal glands (3 hits), the trunks of
chicken stage 36 embryos (4 hits) and multiple-tissue
preparations (2 hits). The AVD hits, in turn, corresponded
to mRNAs isolated from lymphoid tissues (1), intestine
(1), ovary (2), the chondrocytes of cartilage (6), multiple-
tissue preparations (4), splenic T cells (2), pituitary gland,
hypothalamus and pineal gland (1), and PBL macro-
phages (77).
Discussion
Here, we report the biochemical and structural characteri-
zation of BBP-A, produced efficiently both in E. coli and
Spodoptera frugiperda cells. This study demonstrates that
BBP-A can be classified as a new member of the AVD fam-
ily: BBP-A binds BTN with high affinity like all the other
known members of the family [4,24,33] and has the β-
barrel fold characteristic of AVD and of the more hetero-
geneous calycin superfamily of proteins [34]. The binding
mode of BTN to BBP-A (Figure 6) is also highly similar to
that observed in the known structures of AVD [9,23],
AVR2 [24] and AVR4 [25]. The BBP-A protein is, however,
biochemically and structurally clearly distinguishable
from chicken AVD and the AVRs [1,4,18,24,25]. There are
also differences in the immunological properties of BBP-
A and AVD, since immunoblot and dot-blot analyses with
polyclonal AVD antibodies did not show cross-reactivity
between BBP-A and AVD (Figure 4).
Does BBP-A represent the earlier reported BBPs, BBP-I or
BBPII? Based on the biochemical characterization of BBP-
I [11,35-37], and BBP-II [14,15], this seems not to be the
case. The [3H]-biotin dissociation rate constant of BBP-I
reported in 1978 by Meslar and co-workers [11] is 2–4
times higher than that determined for bBBP-A and even
5–12 times higher in comparison to the glycosylated
iBBP-A, which has a dissociation rate of [3H]biotin (Figure
9) in the same range as reported for streptavidin [29]. The
pI (4.6) of the BBP-I protein differs from that calculated
for BBP-A (pI = 9.75), too. Moreover, the reported N-ter-
minal sequences of BBP-I and BBP-II do not match the
sequence of BBP-A [18]. In conclusion, the BBP-A protein
reported here seems to be a novel protein not described in
any previous publications.
In order to study the molecular details of ligand recogni-
tion by BBP-A and compare the ligand-binding properties
of BBP-A with the previously determined structures of
AVD [9], streptavidin [8], AVR4 [25] and AVR2 [24], we
crystallized bBBP-A in complex with BTN. Surprisingly, in
one of the two BBP-A crystals that were analyzed, BSO was
found bound to BBP-A even though only BTN was added
in the co-crystallisation experiments. To our knowledge,
this complex is unique, as no other protein structure has
been reported in complex with BSO. What can be the
source of the bound BSO? Based on the crystallization
conditions (see Methods), it is not easy to say why one
structure bound BTN and the other BSO. It is known that
some BTN preparations may carry minor amounts of BSO
[38], but based on mass spectrometry analysis (data not
shown) no detectable amounts of BSO were found in the
diluted BTN solution that was used for crystallization.
One possibility is that the source of the BSO ligand seen
in the BBP-A – BSO structure is BTN that had undergone
oxidation during crystallization. Another possibility is
Stereo image of electron density around the BSO ligand of th  BBP-A – BSO structureFigure 7
Stereo image of electron density around the BSO lig-
and of the BBP-A – BSO structure. The additional oxy-
gen atom on the BSO ligand (in comparison to BTN) is 
indicated by an arrow. The 2Fo-Fc (blue) and Fo – Fc (red) 
maps calculated without the ligand but drawn around BSO of 
the final model are shown at the level of 1.0 and 3.0 sigma, 
respectively.Page 10 of 20
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Stereo images of the 1–3 and 1–4 subunit interfaces of BBP-A and AVDFigure 8
Stereo images of the 1–3 and 1–4 subunit interfaces of BBP-A and AVD. (a) The 1–3 subunit interface of the AVD 
[PDB: 1VYO] [68] structure superimposed with the corresponding interface of the BBP-A – BSO structure. The carbon atoms 
of amino acids from BBP-A and AVD are coloured light grey and blue, respectively. Amino acids and β-sheets are numbered. 
Two occurrences of Ala97 in the BBP-A structure are indicated by arrows. (b, c) A simplified view of the 1–4 interface of the 
BBP-A – BSO (b) and AVD [PDB: 2AVI] [9] (c) structure after superimposition. The atoms of the non-conserved side chains of 
amino acids within 4 Å of subunit 1 of either the BBP-A or AVD structure are shown. For clarity, Met96 and Thr110 of BBP-A 
as well as the equivalent residues of AVD (Thr95 and Asp109) are not shown, and only one half of the symmetrical 1–4 inter-
face is shown. The carbon atoms of residues from subunit 1 and 4 are respectively coloured light grey and green in BBP-A, and 
grey and blue in AVD. Amino acids and β-sheets are numbered.
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unknown catalytic mechanism, but experimental proof
for this hypothesis is lacking and the final explanation for
the presence of BSO in one of the BBP-A structures
remains to be studied.
The BBP-A – BSO structure inspired us to investigate
whether BBP-A recognizes BSO with altered affinity in
comparison to BTN. We analysed the binding of the fully
oxidised sulfone form of BTN, too. To our surprise, the
dissociation rate of BSO (fluorometric analysis at 40°C,
Table 2) from BBP-A was similar or even slower than the
dissociation rate of BTN (fluorometric and radiobiotin
analysis at 40°C), whereas in the case of AVD the dissoci-
ation rate of BSO was more than 20 times higher in com-
parison to BTN (for AVD, the dissociation rate of BSO was
determined using fluorometric analysis at 50°C (data not
shown), whereas the dissociation of BTN was determined
using radiobiotin assay at 50°C (Figure 9)).
This is the first reported case, to our knowledge, where the
product of a naturally occurring gene encoding a BTN
Biotin dissociation analysisF gure 9
Biotin dissociation analysis. The dissociation of [3H]biotin from various proteins was determined over time. The individual 
dissociation rates of [3H]biotin measured for bBBP-A (black triangles), bBBP-A(A74S) (grey triangles), bBBP-A(T118F) (white 
triangles) and iBBP-A (black circles) are shown. Solid lines represent linear fit to data sets. Data measured previously for AVR2 
(black rectangles), AVR6 (white rectangles) and AVR4 (white tilted rectangles), all produced in bacteria, are also shown [24, 
28]. Data measured for chicken AVD (tilted black rectangles) are presented, too [42]. AVR6 and AVR4 carried the mutations 
C58S and C122S, respectively, which prevented the formation of intersubunit disulphide bridges [33]. The dissociation rates 
for streptavidin are shown as a dotted line according to [29].Page 12 of 20
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Isothermal titration calorimetry analysis of bBBP-A and AVDFigure 10
Isothermal titration calorimetry analysis of bBBP-A and AVD. Binding thermograms measured for (a) AVD-BTN, (b) 
AVD-BSO, (c) AVD – D-biotin sulfone, (d) bBBP-A – BTN, (e) bBBP-A – BSO and (f) bBBP-A – D-biotin sulfone complexes are 
shown at the upper part of the graphs. Non-linear least square curves (at the lower part of each graph) were fitted to 
enthalpies integrated from the individual titrations. For each titration, 0.5 mM ligand solution was used. The reaction volume 
was 10 μl except for the first titration, which was done in 2 μl.
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Fluorescence spectroscopy analysis of BBP-A and AVDigure 11
Fluorescence spectroscopy analysis of BBP-A and AVD. (a) Emission spectra of BBP-A in the absence of ligand (black) 
and with BTN (green), BSO (blue) or D-biotin sulfone (red) are shown. (b) Emission spectra of AVD. (c) Dissociation of D-
biotin sulfone from BBP-A displaced with excess of BTN at 40°C. The measured emission intensity is plotted over time and 
corrected using the emission decay data from control measurements, which were made for protein saturated with BTN. Exci-
tation at 280 nm was used.
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/8binder shows equally high affinity to a ligand other than
BTN. Based on DSC analysis the studied ligands did not
differ significantly in their effect on the thermal stability
of BBP-A and AVD (Table 2). Nor did the measured bind-
ing enthalpies vary significantly over ligand sets between
AVD and BBP-A (Table 2). Overall, these ligand binding
analyses suggest that all the studied ligands are efficiently
associated (high negative binding enthalpy) with BBP-A
and AVD. However, the determined dissociation rate of
BTN from AVD was significantly lower than the dissocia-
tion rates of BSO and D-biotin sulfone, whereas the
observed dissociation rates of the same ligands from BBP-
A were rather similar to each other, the slowest observed
for BSO. As a conclusion, it is the different dissociation
rather than association rates that determines the ligand-
binding preferences of BBP-A and AVD; out of the three
ligands studied, AVD prefers BTN, whereas BBP-A seems
to prefer BSO. Moreover, it is well known that the
extremely slow dissociation of BTN from AVD is the main
determinant of the high affinity binding [1].
One possible explanation for the differences in the disso-
ciation rates of the studied ligands is the weaker structural
stability of BBP-A as compared to AVD (Table 1). It has
been experimentally shown, that binding of BTN to
streptavidin lowers the rate of H/D exchange in large parts
of the structure [10] at least partially due to the positive
structural cooperativity in the binding process (thor-
oughly explained in [39]), i.e. improved packing and
compactness of not only the ligand-binding site but of
entire subunits, too. The weaker stability, or lower level of
"compactness", of the entire BBP-A tetramer can therefore
explain the differences in the observed ligand-binding
properties of AVD and BBP-A. The BBP-A barrel fold may
also be considered more flexible or dynamic than the AVD
barrel, which could lead to a higher rate at which BTN is
dislodged from the binding pocket, possibly by a mecha-
nism similar to that presented by Hyre et al. for streptavi-
din [40].
What are the structural determinants that specify the rec-
ognition of BSO and why does the affinity of BSO meet
that of BTN for BBP-A? The BBP-A – BSO structure is strik-
ingly similar to the BBP-A – BTN structure – even the addi-
tional D-sulfoxide moiety of the ligand in the BBP-A –
BSO structure does not seem to alter the binding pocket of
BBP-A as compared to the BBP-A – BTN structure (Figure
6). One clear difference can, however, be detected: the
hydrogen bond present in the BBP-A – BTN complex
structure between Glu102 and BTN is missing in the BBP-
A – BSO structure due to the different conformation of
Glu102 in the two structures. Moreover, in the BBP-A –
BSO structure, the carboxylate side-chain of Glu102 forms
a salt-bridge with the guanidinium group of the Arg115
side-chain within the same subunit (in chains B and D) or
is hydrogen bonded to a structural water molecule (in
chains A and C), interactions that are not seen in the BBP-
A – BTN complex. Arg115 is one of the conserved amino
acids found at the 1–2 subunit interfaces of all known
structures of members of the AVD family, but its confor-
mation varies within the family (data not shown). This
suggests that, in addition to the residues at the ligand-
binding pocket, the type and conformation of residues at
the subunit interfaces may regulate ligand binding, e.g. by
allowing or disabling alternative hydrogen bonding net-
works.
Conclusion
Our present study reveals that chicken has an avidin-like
protein, BBP-A in its biotin-binding repertoire. Even
though similar to AVD according to its three-dimensional
structure and biotin-binding properties, i.e. the high affin-
ity for BTN, BBP-A has several unique features – the ther-
mal stability and immunological cross-reactivity of BBP-A
is very different as compared to AVD. Furthermore, BBP-A
is the first example of a protein from the AVD family that
naturally has equally high affinity for BTN and for a non-
BTN ligand. The biological function of BBP-A is not
known, but since it binds both BSO and BTN with high
affinity, it may have a function in the storage or delivery
of BTN to an embryo as has been suggested in earlier stud-
ies for BBP-I and BBP-II [14,17]. In addition to providing
clues of biological function and information about
biotin-binding determinants in proteins, the high-resolu-
tion structure and biochemical analysis of BBP-A makes
this novel protein attractive material for protein engineer-
ing and bio(nano)technological applications. For exam-
ple, BBP-A could be covalently combined with AVD or
AVR polypeptide using a circular permutation strategy
[41,42] or used as a scaffold in the development of artifi-
cial enzymes [43].
Methods
Preparation of expression constructs
A cDNA clone of BBP-A [GenBank: BX930135] was
obtained from the UK Chicken EST Consortium (ARK-
Genomics). For insect cell production the cDNA, which
included the sequence encoding for a putative signal pep-
tide [18], was PCR amplified and cloned into a
pFASTBAC1 vector (Invitrogen). The following primers
were used: 5'BBP-A+signal (5'-AAAAGATCTATGGAG-
CACCTCCGCTG) and 3'BBP-A (5'-ATTTAAGCTTACTT-
GACACG GGTG), in which the restriction enzyme
cleavage sites for BglII and HindIII, respectively, are
shown in italics. In order to express BBP-A in E. coli, the
original signal sequence of BBP-A was replaced with the
OmpA signal peptide from Bordetella avium [44] by clon-
ing into the pGemTeasy vector (Promega) containing the
OmpA-signal and flanking attL recombination cloning
sequences [30]. The construct was then transferred to thePage 15 of 20
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nation (Invitrogen). 5'BBP-A-core (5'-AAAGGTACCAG-
GAAGTGCGAGC; KpnI) and 3'BBP-A were used as the
primers for PCR. The nucleotide sequences of the final
expression vectors were confirmed by DNA sequencing.
The mutagenesis of BBP-A cloned in the pGemTeasy plas-
mid was performed using the QuikChange mutagenesis
method (Stratagene, La Jolla, CA, USA). The BBP-A
mutants were transferred to the pBVboostFG expression
vector essentially as described previously [46].
Protein expression and purification
BBP-A and its mutated forms were produced in E. coli BL-
21(AI) cells (Invitrogen) as previously described [30]. The
mutation A74S was created in order to study the signifi-
cance of this residue for BTN binding (in AVD the side
chain of the equivalent Ser73 forms a hydrogen bond with
BTN). T118F, in turn, was created in order to increase the
subunit contact area and consequently the stability of
BBP-A; in AVD, I117Y was found to increase the stability
of the protein [28]. iBBP-A, employing its natural signal
peptide, was expressed in the eukaryotic host, Spodoptera
frugiperda, using the Bac-to-Bac baculovirus expression
system (Invitrogen). The proteins were isolated using 2-
iminobiotin affinity chromatography (Affiland S. A.,
Liege, Belgium) as described elsewhere [30,47]. AVD iso-
lated from chicken egg-white (wtAVD; Belovo S. A., Bas-
togne, Belgium) and AVD produced in E. coli (bAVD) [30]
were used as control proteins throughout this study.
Chemical synthesis of BSO and D-biotin sulfone
The syntheses of BSO and D-biotin sulfone were per-
formed using a procedure described by Melville [48]. The
melting points of the BTN derivatives were 201–202°C
(lit. 200–203°C [48]) for BSO and 275–277°C (lit. 274–
275°C [49]) for D-biotin sulfone. From ESI-MS analysis
(see below) the following values were obtained: BSO, cal-
culated molecular weight (C10H16N2O4S1) = 260.31, [M-
H]- m/z = 259.0753 and measured m/z = 259.0388; D-
biotin sulfone, calculated molecular weight
(C10H16N2O5S1) = 276.31, [M-H]- m/z = 275.0702 and
measured m/z = 275.0184.
Stability analysis
The stability of BBP-A was analysed by SDS-PAGE as
described previously [22]. Prior to analysis, the protein
sample was acetylated in vitro and subsequently subjected
to thermal treatment for 20 min in the presence of SDS
and 2-mercaptoethanol. The oligomeric state of the
treated protein was assessed by SDS-PAGE using Bio-Safe
Coomassie (Bio-Rad) staining.
Differential scanning calorimetry
Differential scanning analysis was performed in 50 mM
NaPO4 buffer (pH 7.0) containing 100 mM NaCl as previ-
ously described [33]. The concentration of the analyzed
proteins was between 0.2 and 0.6 mg/ml. In samples con-
taining a ligand, the molar ligand concentration was three
times as high as the protein subunit concentration. The
samples were scanned from 25 to 130°C at a rate of
0.92°C/min.
Gel filtration chromatography
Gel filtration analysis was performed with a ÄKTA™ puri-
fier HPLC instrument (Amersham Biosciences) equipped
with Superdex 200 10/300 GL column (Tricorn) as previ-
ously described [50]. A buffer containing 50 mM NaPO4
and 650 mM NaCl (pH 7.0) was used as the liquid phase.
Biotin-complexed proteins were prepared by incubating
the sample in the presence of 0.22 mM BTN 15 min prior
to analysis.
Mass spectrometry
The mass spectrometric studies were performed with a
Micromass LCT ESI-TOF instrument equipped with a Z
geometry electrospray ion source TOF detector. The anal-
ysis of BBP-A was performed as previously described [30].
Before analysis, the sample was dialysed against distilled
water and lyophilised. MS analysis of the BTN used in the
crystallization experiments with BBP-A was performed to
determine whether BSO was present in the ligand solu-
tion. The amount of BSO in the sample was below the
detection limit of the method (less than 1%). The detec-
tion limit was determined by making mixtures of 10 μg/
ml (41 μM) of BTN with 1 (3.8 μM), 0.5 (1.9 μM) or 0.1
μg/ml (0.38 μM) of BSO.
Ligand-binding analyses
The dissociation rate of [3H]biotin (Amersham) was
measured at various temperatures with a competition
assay as described previously [29]. Measurements were
carried out in 50 mM NaPO4 buffer containing 100 mM
NaCl.
The dissociation rate of the fluorescent biotin conjugate
ArcDia™ BF560-biotin (ArcDia Ltd., Turku, Finland) was
measured as reported previously [30]. The measurements
were made at 25°C in 50 mM NaPO4 buffer (pH 7.0) con-
taining 650 mM NaCl using a PerkinElmer LS55 lumi-
nometer.
The energetics of biotin binding was determined with a
VP-ITC (MicroCal™) Isothermal Titration Calorimeter.
Measurements were performed at 25°C in degassed 50
mM NaPO4 buffer (pH 7.0) containing 100 mM NaCl. In
order to calculate the enthalpies of binding (ΔH) for BBP-
A and AVD, the cell used for measurements was filled withPage 16 of 20
(page number not for citation purposes)
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/830 μM protein solution. BTN, BSO or D-biotin sulfone
(0.5 mM) was then added to the measurement cell using
15 equal volume injections (10 μl) and at 240 second
intervals. The data were analysed with Origin 7.0 software
using the "One Set of Sites" method. The titration curve
(heat change μcal/injection) resulting from the 15 injec-
tions was analysed by fitting the data to a nonlinear least
square curve. We only determined the enthalpy of binding
from these experiments, since the estimation of binding
constants directly from the data was impossible due to the
tight binding.
In order to study the intrinsic fluorescence of the proteins,
the emission spectra of bBBP-A and wtAVD in 50 mM
NaPO4 buffer (pH 7.0) containing 650 mM NaCl were
measured using a PerkinElmer LS55 spectrofluorometer
and excitation at 280 nm (slit 2.5 nm). During the analy-
sis, protein solutions (100 nM) were continuously mixed
using an integrated magnetic stirrer and maintained at
25°C using a circulating water bath. The emission spectra
were also measured after addition of 200 nM ligand (BTN
or its oxidised forms) to the protein solutions.
Fluorescence spectroscopy was also used to measure the
rate of protein-ligand dissociation. These experiments
were made at 40°C in order to measure the dissociation
events within an experimentally applicable timescale.
Firstly, the emission intensity of bBBP-A or wtAVD (50
nM) was measured at 350 nm (slit 10 nm) in the presence
of BTN, BSO or D-biotin sulfone (100 nM). Secondly, in
order to detect and quantify the dissociation events, a
1000-fold molar excess (100 μM) of BTN (BSO in case of
determination of BTN dissociation) was added to the
samples and the measurements were recorded for 3600
seconds. The measured spectral properties of each pro-
tein-ligand complex (i.e. the emission intensity of the pro-
tein-ligand complex) were used to create a single-phase
dissociation model, which was fitted to the data. For
example, in the case of the dissociation of BSO from BBP-
A and binding of BTN to BBP-A, the dissociation process
was observed as a decrease in the emission intensity (Fig-
ure 11c). The decrease in the fluorescence signal obtained
in the control measurement performed in the presence of
a 1000 molar excess of BTN was corrected during data
analysis.
Deglycosylation analysis
The BBP-A protein produced in insect cells was treated
with Endoglycosidase H (New England Biolabs) to see if
it was glycosylated. Wild-type AVD was used as a control
protein. Prior to treatment, the analysed proteins were
denatured by boiling them in the presence of 2-mercap-
toethanol and SDS. Deglycosylation was performed over-
night at 37°C. The samples were then boiled and
subjected to SDS-PAGE analysis followed by staining with
Bio-Safe Coomassie (Bio-Rad).
Immunological analysis
The cross-reactivity of polyclonal AVD antibodies with
BBP-A was studied using immunoblot and dot-blot anal-
yses. The polyclonal rabbit antibodies TdaVIII [51] and an
AVD antibody (University of Oulu, Finland) were used
(dilution 1:5000) in Western blotting to analyse a 10 μg
sample of BBP-A produced in E. coli. Three different
amounts, 0.1, 1 and 10 μg of wtAVD, were used as con-
trols in this experiment.
Dot-blot analysis was performed using only the TdaVIII
antibody and 10 μg of BBP-A produced either in E. coli or
in insect cells. AVD from chicken was used as a control
(0.04–1.33 μg).
Crystallization and diffraction data collection
Random and sparse matrix screens [52] prepared with the
HamiltonSTAR robot in the Institute of Biotechnology at
the University of Helsinki were initially used to search for
suitable conditions for crystallization of BBP-A. Sitting
drops of equal volumes (100 nl) of sample and well solu-
tion were automatically prepared by the Cartesian
MicroSys robot on 96-well Greiner 3-SQ plates at 20°C.
For optimization, the drop size was increased to 2 μl and
crystallization was performed on conventional 24-well
crystallization plates (Nextal/Hampton Research) using
the vapour diffusion method and either sitting or hanging
drops. In order to prepare BBP-A – BTN complexes, BTN
(Sigma) diluted in buffer containing 5 mM Tris (pH 8.8)
and 8 mM CHES (pH 9.5) was added to the protein sam-
ples in an approximate 1:10 molar ratio before crystalliza-
tion. Two crystals were used to collect diffraction data and
were obtained from conditions where 1 μl of protein solu-
tion (~0.4 mg/ml) containing 50 mM sodium acetate (pH
4.0) and 100 mM sodium chloride, and 1 μl of well solu-
tion containing either 2 M ammonium sulphate and 5%
isopropanol (v/v) (BBP-A – BTN crystal) or 0.2 M sodium
acetate, 0.1 M Tris (pH 8.6) and 30% (v/v) PEG 4000
(BBP-A – BSO crystal) were used. The diffraction data were
collected at the MAX-lab beam line I711 (Lund, Sweden)
at 100 K using a MarCCD detector. The BBP-A – BTN and
BBP-A – BSO crystals were cryoprotected by adding 0.8 μl
of 100% glycerol and 1 μl of 4 M sodium formate, respec-
tively, to the crystallization drops just prior to flash-freez-
ing in a 100 K liquid nitrogen stream (Oxford
Cryosystem). Diffraction data were processed with pro-
grams of the XDS program package [53]. The data collec-
tion statistics are summarized in Table 3.
Structure determination
The X-ray structures of BBP-A – BTN and BBP-A – BSO
were solved using the molecular replacement programPage 17 of 20
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AVR2 [PDB: 1WBI] [24] was used as a trial model in
Amore to solve the BBP-A – BTN structure. The BBP-A –
BSO structure, in turn, was solved using the BBP-A – BTN
structure as a search model in Amore. The best solutions
from molecular replacement were selected as input for
automatic model building with ARP/wARP [57]. The
models were refined with Refmac5 [58], and modified
and rebuilt with O [59]. Solvent atoms were added to the
model with an automatic procedure in ARP/wARP [60]
and other non-protein atoms were built manually in O.
The coordinate file of the BSO ligand was obtained from
the Cambridge Structural Database (CSD version 5.26)
and molecular topologies of BSO were created with
PRODGR [61]. The BBP-A structures were analyzed with
the programs PROCHECK [62] and WHATIF [63]. The
structure determination statistics are summarized in Table
3. The coordinates and structure factors of the BBP-A –
BTN and BBP-A – BSO structures have been deposited in
the Protein Data Bank with entry codes 2C1Q and 2C1S,
respectively.
Miscellaneous methods
Figures 2, 3, 4, 5 were created with the PyMOL Molecular
Graphics System [64] and edited with the Corel Draw11
program suite. The multiple sequence alignment shown
in Figure 2 was created using the program Malign imple-
mented in BODIL [65]. Electrostatic potentials were calcu-
lated using the ABPS [66] plugin of PyMOL. The programs
Contact and Areaimol [67] of the CCP4i suite were used
to calculate the solvent accessible surface areas and to
identify residues at the subunit interfaces, respectively.
Expressed sequence tag (EST) databases at NCBI were
searched (blastn [32]) using the cDNA of BBP-A [Gen-
Bank: BX930135] and AVD [GenBank: X05343] as query
sequences.
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